Bidgely to Showcase AI-Powered Energy Intelligence at IDC European Utilities Xchange March 2, 2026 Keynote speech, executive forums, and roundtables feature strategies for accelerating grid modernization
ViiV Healthcare reports positive 12-month data showing investigational bNAb lotivibart (N6LS) maintains high levels of viral suppression in long-acting HIV treatment regimen February 25, 2026 94% of adults on stable therapy maintained viral suppression with intravenous lotivibart dosed every four months in combination with long-acting cabotegravir These phase IIb results reinforce lotivibart’s ultra long-acting potential, with the trial progressing to evaluate a twice-yearly intravenous dosing interval
Alkermes to Present at the TD Cowen 46th Annual Health Care Conference February 24, 2026 Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026 at 9:10 a.m. ET (2:10 p.m. GMT). The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days. About [...]
Toshiba Showcases End-to-End Innovations Shaping What’s Next in Retail at EuroShop 2026 February 23, 2026 At EuroShop, Toshiba showcases intelligent, scalable solutions that combine AI, computer vision, and energy-efficient design to transform the future of retail.
New ECCO data show subcutaneous (SC) infliximab (Remsima™ SC) effectively recaptures and maintains disease control after drug holiday February 16, 2026 A new post-hoc analysis from the LIBERTY studies, presented at ECCO 2026, demonstrated that initiating subcutaneous (SC) infliximab (Remsima™ SC) after a treatment interruption following intravenous (IV) infliximab induction helps patients with Crohn’s disease (CD) and ulcerative colitis (UC) recapture and maintain disease control1 The results demonstrated that SC infliximab provides an effective and safe option to regain clinical control after a planned or unplanned treatment interruption More than a total of 30 accepted abstracts including one oral and one digital oral presentation and eight posters, reinforce Celltrion’s commitment to inflammatory bowel disease (IBD) research aimed at enhancing patient outcomes
Allegion to Attend 2026 Barclays Industrial Select Conference February 12, 2026 Allegion plc (NYSE: ALLE) President and CEO John H. Stone will discuss the company’s long-term strategy at the 2026 Barclays Industrial Select Conference on Thursday, Feb. 19. The conference will be held at Loews Miami Beach Hotel. A live listen-only webcast will be accessible via Allegion’s investor website at investor.allegion.com or directly by clicking here. [...]
World Governments Summit 2027 Date Announced, Following Largest-Ever Global Participation February 10, 2026 Largest edition in the summit’s history convened 6,250+ global leaders, policymakers, and experts from 150+ countries World leaders, including presidents from Switzerland, Sierra Leone, and beyond, lead strategic dialogues
Promega Unveils Cellular Target Engagement Technology Aimed at Expanding the Druggable Proteome at SLAS 2026 February 9, 2026 TarSeer™ BRETSA™ Target Engagement System enables studies for difficult proteins early in drug discovery
High-end Aesthetic Brand ‘Lorient’ Gains Global Prestige at IMCAS 2026 February 2, 2026 Lorient, a premium aesthetic brand, announced that it has drawn global attention at the 27th IMCAS World Congress 2026 in Paris, attracting over 15,000 professionals and demonstrating its leadership in aesthetic innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260131322203/en/ The highlight was a session led by Dr. Jani van Loghem, a [...]
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System January 30, 2026 Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability